Normally, the BRAF gene is activated only during cell proliferation, but BRAF mutations remain active, activating the downstream MAPK (mitogen-activated protein kinase) signaling pathway and causing uncontrolled cell invasion and proliferation, leading to the rapid progression of melanoma in situ to metastatic malignant melanoma [4]. Here, BRAF is linked to melanoma.